Prospective Observational Post-marketing Study of Tafluprost 0.0015%/Timolol 0.5% Combination Ophthalmic Solution for Glaucoma and Ocular Hypertension: Short-Term Efficacy and Safety

Introduction The intraocular pressure (IOP)-lowering effect and safety of tafluprost 0.0015%/timolol maleate 0.5% combination ophthalmic solution (Taf–TFC) were investigated in a real-world clinical setting. Methods A prospective up to 2-year (more than 1 year) observational study has been initiated...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Ophthalmology and therapy 2016-12, Vol.5 (2), p.191-206
Hauptverfasser:	Takagi, Yasutaka, Osaki, Hirotaka, Yamashita, Tomohiro, Kai, Yasuhiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Internal Medicine Medicine Medicine & Public Health Ophthalmology Original Research
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!